Translational Science

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.